Efficacy and safety of reduced‐dose chemotherapy plus immunotherapy in patients with lung squamous cell carcinoma: A <scp>real‐world</scp> observational study

Ganlu Ouyang(Sichuan University), Lu Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanyang Liu(Sichuan University), Feng Luo(The University of Queensland), Lin Huang(Sun Yat-sen University), Jiewei Liu(Guangzhou Center for Disease Control and Prevention)
Cancer Medicine
September 1, 2023
Cited by 9


Related Papers